Research published in the journal JAMA Oncology argues that major lifestyle changes can significantly delay the onset of cancer.
Research published in the journal JAMA Oncology argues that major lifestyle changes can significantly delay the onset of cancer.
To prove their hypothesis, the authors designed a prospective cohort study that analyzed cancer and lifestyle data from 3 sources:
The authors divided the all-white participants into 2 cohorts (89,571 women and 46,339 men)—low-risk group and high-risk group—based on whether they had a “healthy lifestyle” pattern. The low-risk group (healthy lifestyle) had to meet the following criteria:
The authors then estimated the proportion of cases and deaths of carcinomas (except skin, brain, lymphatic, hematologic, and nonfatal prostate malignancies) that could potentially be prevented by calculating the population-attributable risks (PARs). This was a comparison of incidence and mortality of total and major individual carcinomas between the 2 cohorts.
Only 16,531 women and 11,731 men fell in the low-risk group, the authors observed. The PARs for incidence and mortality of total carcinomas were 25% (low-risk) and 48% (high-risk) in women, and 33% (low-risk) and 44% (high-risk) in men. The following were the PARs statistics for the individual cancers:
Similar trends were observed for mortality, the authors report. The PARs were 4% and 12% for breast cancer incidence and mortality, and 21% for fatal prostate cancer.
These are significant numbers, considering that a majority of these cancers have very high mortality risks, primarily as a result of delayed detection due to a lack of specific symptoms. Based on their findings the authors believe that a substantial cancer burden can be prevented through lifestyle modification in the United States.
Reference
Song M, Giovannucci E. Preventable incidence and mortality of carcinoma associated with lifestyle factors among white adults in the United States. JAMA Oncol. 2016;2(9):1154-1161. doi: 10.1001/jamaoncol.2016.0843.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More